Sight Sciences, Inc., (SGHT): Price and Financial Metrics


Sight Sciences, Inc., (SGHT): $9.16

-0.05 (-0.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SGHT Stock Price Chart Interactive Chart >

Price chart for SGHT

SGHT Price/Volume Stats

Current price $9.16 52-week high $42.57
Prev. close $9.21 52-week low $6.25
Day low $8.73 Volume 108,900
Day high $9.29 Avg. volume 327,429
50-day MA $8.39 Dividend yield N/A
200-day MA $16.12 Market Cap 435.92M

Sight Sciences, Inc., (SGHT) Company Bio


Sight Sciences, Inc., an ophthalmic medical device company, engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.


SGHT Latest News Stream


Event/Time News Detail
Loading, please wait...

SGHT Latest Social Stream


Loading social stream, please wait...

View Full SGHT Social Stream

Latest SGHT News From Around the Web

Below are the latest news stories about Sight Sciences Inc that investors may wish to consider to help them evaluate SGHT as an investment opportunity.

Sight Sciences to Participate in the Upcoming Citi Virtual Healthcare Conference

MENLO PARK, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the upcoming Citi Virtual Healthcare Conference. Sight Sciences’ management is scheduled to participate in a fireside chat February 23, 2022, at 8:45am PT. Interested parties may access a live and archived webcast of the fireside

Yahoo | February 21, 2022

Fulgent Genetics (FLGT) to Post Q4 Earnings: What's in Store?

In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.

Yahoo | February 21, 2022

Medtronic (MDT) to Report Q3 Earnings: What's in Store?

Medtronic (MDT) might report low procedure volumes in the fiscal third quarter in markets where its technologies are used in more deferrable procedures.

Yahoo | February 18, 2022

Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma

Educational campaign aims to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an earlier surgical intervention for glaucomaMENLO PARK, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise

Yahoo | February 17, 2022

Why Earnings Season Could Be Great for Sight Sciences (SGHT)

Sight Sciences (SGHT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | February 8, 2022

Read More 'SGHT' Stories Here

SGHT Price Returns

1-mo N/A
3-mo -20.76%
6-mo -47.87%
1-year N/A
3-year N/A
5-year N/A
YTD -47.87%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6356 seconds.